Ritlecitinib Tosilate, Placebo for pf-06651600-15
B7981119
Phase 2 small_molecule active
Quick answer
Ritlecitinib Tosilate, Placebo for pf-06651600-15 for HIDRADENITIS SUPPURATIVA is a Phase 2 program (small_molecule) at Pfizer Ireland Pharmaceuticals Unlimited Company with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Pfizer Ireland Pharmaceuticals Unlimited Company
- Indication
- HIDRADENITIS SUPPURATIVA
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active